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ABSTRACT 
Bacteriocin production is regarded as a desirable probiotic trait that helps colonisation and 
persistence in the gastrointestinal tract (GIT). Strains of Lactobacillus salivarius, a species 
associated with the GIT, are regarded as promising probiotic candidates and have a number 
of associated bacteriocins documented to date. Among these include multiple class IIb 
bacteriocins (salivaricin T, salivaricin P and ABP-118) and the class IId bacteriocin 
bactofencin A, that show activity against medically important pathogens. However, the 
production of a bacteriocin in laboratory media does not assure production under stressful 
environmental conditions, such as those encountered within the GIT. To allow this issue to be 
addressed, the promoter regions located upstream of the structural genes encoding the 
aforementioned L. salivarius bacteriocins were fused to a number of reporter proteins (green 
fluorescent protein [GFP], red fluorescent protein [RFP] and luciferase [Lux]). Of these only 
transcriptional fusions to GFP generated signals of sufficient strength to study promoter 
activity in L. salivarius. While analysis of the class IIb promoter regions revealed relatively 
weak GFP expression, assessment of the promoter of the anti-staphylococcal bacteriocin 
bactofencin A indicated a strong promoter that is most active in the absence of the 
antimicrobial peptide and positively induced in the presence of mild environmental stresses, 
including simulated gastric fluid. Taken together this data provides information on factors 
that influence bacteriocin production, which will assist in developing strategies to optimise 
the in vivo and in vitro production of these antimicrobials.  
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INTRODUCTION 
Bacteriocins are a heterogeneous family of small, ribosomally synthesised peptides with 
antimicrobial activity produced by many bacterial species (1-3). These antimicrobials can 
have a broad or narrow spectrum of activity and have considerable potential as agents in food 
preservation and in biomedical applications. Bacteriocin production is considered an 
important trait of gut-derived bacteria influencing microbial populations within the intestinal 
tract (review see (4)). Lactobacillus salivarius is a species associated with the GIT with many 
associated probiotic traits. L. salivarius strains are frequently producers of class IIa, IIb and 
IId unmodified bacteriocins (5-9). Class IIa bacteriocins are generally designated as pediocin-
like peptides, class IIb comprise the two-component unmodified peptides and class IId 
bacteriocins are often categorised on the basis of their dissimilarity to other class II peptides 
(10).  
L. salivarius NCIMB 40829 (LSUCC118™) is an extensively studied strain and 
produces the class IIb two-peptide bacteriocin ABP-118 (11). The in vivo functionality of the 
ABP-118 bacteriocin and its effectiveness in eliminating a GIT pathogen in a mouse model 
has been previously demonstrated (12). Closely-related variants of ABP-118, such as 
salivaricin P, and indeed other two-peptide bacteriocins, such as salivaricin T, have also been 
isolated from several intestinal L. salivarius strains (7, 13). Production of and immunity to 
these bacteriocins relies on the coordinated expression of at least 12 genes (8, 11, 13). More 
recent work has led to the identification of a novel class IId bacteriocin, bactofencin A, 
produced by porcine intestinal isolates of L. salivarius (9). This bacteriocin gene cluster 
consists of just 4 genes including the structural peptide, BfnA, which shows little identity to 
previously isolated bacteriocins but shares some similarity with eukaryotic cationic peptides. 
This bacteriocin was demonstrated to have antimicrobial activity against medically important 
pathogens, including Staphylococcus aureus (9). The level of production of bactofencin A 
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and indeed many other bacteriocins in vivo and to how their production is influenced by 
stressful environmental conditions are as yet unknown. This is despite the fact that it has been 
documented that bacteriocin production can be sensitive to environmental changes and 
parameters including temperature, pH and growth medium (14-16). Research of this nature is 
critical with respect to the successful use of bacteriocin producing strains for food and/or 
medical applications.  
With respect to what is known already, it is clear that the regulation of bacteriocin 
production can be complex and in some cases involves a quorum sensing cell-density 
dependant mechanism that relies on a pheromone-like peptide and a cognate two component 
regulatory system (17). The inducing peptides (IP), thought to be produced at a low basal 
level in early growth, can reach a critical threshold concentration either due to an 
accumulative process or by increased production elicited by an environmental stimulus. Once 
the required IP level is reached, the signal is processed by the two component system, which 
binds to the promoters of the bacterial structural genes to allow bacteriocin production (17). 
These regulatory mechanisms and the promoter elements involved have been studied in depth 
in the cases of plantaricin (18, 19) and sakacin (20, 21) bacteriocin gene clusters. In some 
cases, most notably in lantibiotic (class I) gene clusters, the bacteriocin itself can function as 
the inducing peptide (22).  
Of the salivaricins that are the focus of our studies, the 3 class IIb non-lantibiotic 
bacteriocins (ABP118, Salivaricin P and T) are predicted to have a IP-associated regulatory 
mechanism similar to that described above (11), whereas the gene cluster associated with the 
class IId bacteriocin bactofencin A does not contain an obvious regulatory mechanism (9). 
With a view to identifying the environmental factors that influence the production of these 
bacteriocins, the putative bacteriocin promoter regions were fused to a reporter gene to detect 
promoter activity under various environmental conditions. More specifically, a stable 
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expression system using the Green Fluorescent Protein (GFP) was established and the 
promoter.gfp fusions were monitored in L. salivarius bacteriocin-producing backgrounds. 
Promoter activity was assessed under a number of environmental conditions, some of which 
simulate the stressful environment of the GIT. This knowledge will allow the development of 
strategies to optimise the production of these bacteriocins in vivo and in vitro and provide 
valuable fundamental insights that will facilitate similar experiments with other bacteriocin-
producing microbes in the future. 
 
MATERIALS AND METHODS 
Bacterial strains and culture conditions 
The Escherichia coli and L. salivarius strains and plasmids used in this study are listed in 
Table 1. E. coli strains were grown aerobically in Luria-Bertani (LB) medium at 37C. L. 
salivarius strains were cultured under anaerobic conditions in MRS (Difco Laboratories, 
Detroit, MI) at 37C for 24-48 h, except for fluorescence expression analysis where cells 
were grown statically at 37C, to achieve microaerobic conditions. Ampicillin (50 µg/mL) 
and Chloramphenicol (Sigma-Aldrich, St. Louis, MO, USA) was added at 10 µg/mL and 5 
µg/mL for E. coli and L. salivarius strains respectively.   
 
In silico analysis of putative promoter regions 
The bacteriocin gene clusters of salivaricin P (13), salivaricin T (8), ABP-118 (11) and 
bactofencin A (9) were analysed using Artemis software (23). Regions upstream of the 
structural peptides and prepeptides were investigated for putative promoter regions using 
BPROM (24), Virtual Footprint (version 3.0) (25) and by manual annotation of the operons. 
Direct repeats were searched for using the Tandem Repeats Finder software (26). 
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DNA manipulations 
Primers used for PCR were purchased from Sigma-Aldrich (St. Louis, MO, USA) and are 
listed in Table S1 in supplemental material. Platinum Taq DNA polymerase (Life 
technologies, Carlsbad, CA, USA) or MyTaq Red mix (Bioline, London, UK) was used for 
PCR amplifications. Restriction enzymes, Klenow DNA polymerase I and T4 DNA ligase 
were all purchased from Roche (Manheim, Germany) and used as outlined in manufacturer’s 
instructions. PCR purification, gel extraction and plasmid preparation kits were obtained 
from Qiagen (Venlo, Netherlands) and used as specified by the manufacturers. The genomic 
DNA of L. salivarius strains was extracted as previously described (27).  
 
Construction of expression plasmids 
The pNZ44 plasmid expressing reporter proteins GFP, DsRed (Red fluorescent protein, RFP) 
and the Lux (luciferase) system were created as follows. The gfp+ gene including a ribosome 
binding site (RBS) was amplified from the plasmid pEVSgfp+ (28) using the primers gfp+For 
and gfp+Rev (Table S1) containing the PstI and XbaI restriction sites. The cloning vector 
pNZ44 and gfp insert were digested with the restriction enzymes PstI and XbaI, ligated 
together and the resulting pNZ44.gfp+ plasmid was transformed into chemically competent 
E. coli DH10B cells (Life Technologies, Calrsbad, CA, USA) and subsequently into L. 
salivarius cells. The DsRed reporter gene (rfp) was amplified from the pDsRed-Express 
vector (Clontech, Mountain view, CA, USA) using the primers DsRed+For and DsRed+Rev 
(Table S1) to create the pNZ44.rfp+ plasmid. These primers incorporated a RBS site and 
altered start codons to reduce the GC content at the beginning of the gene so as to increase 
the likelihood of translation initiation as previously recommended (29). The luciferase genes 
were amplified from the pP2lux plasmid (30) with the lux+For and lux+Rev primers and also 
cloned into the PstI and XbaI sites of pNZ44 to create the pNZ44.lux+ plasmid (Table 2). In 
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certain gfp+ plasmids the p44 promoter was replaced with a constitutive lactobacilli promoter 
(pcysK). Subsequently, putative promoter regions for the bacteriocin operons bactofencin A, 
salivaricin P, T and ABP-118 were amplified from L. salivarius genomic DNA and using the 
BglII and PstI restriction sites were cloned to create transcriptional fusions to the gfp+ gene. 
Constructs created are outlined in Table 2; primers used to create the amplicons for cloning 
are described in Table S1. To generate the 151bp putative promoter region representing 
salprom3, the sequence was synthesised using the gene synthesis service by GeneWiz/Sigma-
Aldrich (St. Louis, MO, USA) including BglII and Pst1 restriction sites to facilitate cloning 
into the pNZ44.gfp plasmid (Fig. S1). Plasmids were transformed into chemically competent 
E. coli DH10B cells (Life Technologies, Carlsbad, CA, USA). Following verification of the 
integrity of the plasmid constructs, they were transformed into electrocompetent L. salivarius 
bacteriocin-producing backgrounds (L. salivarius DPC6502 (bactofencin A producer), L. 
salivarius DPC6488 (salivaricin T and salivaricin L (class IId bacteriocin producer (8)), L. 
salivarius DPC6189 (salivaricin P and bactofencin A producer) and L. salivarius NCIMB 
40829 (LSUCC118™) (ABP-118 producer) to create a bank of gfp+ strains (Table S2). 
Lactobacillus salivarius competent cells and electroporation procedures were performed as 
described previously (31). To create a promoter-less plasmid containing the gfp gene to serve 
as a negative control, the p44 promoter was removed from the pNZ44.gfp plasmid using the 
BglII and PstI restriction sites. The plasmid ends were treated with Klenow DNA polymerase 
and subsequently ligated with T4 DNA ligase. The integrity of the constructs was confirmed 
by sequencing (Beckman Coulter Genomics, Takeley, UK). 
 
Expression of reporter genes in L. salivarius  
To detect fluorescence in L. salivarius strains containing the promoter.gfp+ fusions, cells 
were grown overnight in broth at 37C until stationary phase. Cells were harvested and 
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washed with phosphate-buffered saline (PBS) and subsequently the cell suspensions were 
analysed using an epifluorescence microscope (Olympus BX-51) equipped with a fluorescein 
isothiocyanate filter under the Olympus UPlanFl 100X oil Iris objective lens. Images were 
captured with a DP50 camera (Olympus Co., Toyko, Japan) and analysed with the Olympus 
analySIS software. To detect fluorescence from L. salivarius strains containing 
promoter.rfp+ fusions, cells were prepared as above and analysed using the Olympus 
microscope equipped with a tetramethylrhodamine isothiocyanate filter for red emission. 
 To detect bioluminescence, overnight cultures were inoculated at 1-2.5% in fresh 
MRS broth for L. salivarius cells and in LB broth for E. coli cells and transferred in to 96- 
well plates, incubated and monitored on a Xenogen IVIS 100 system (Xenogen, Almeda, CA, 
USA) at 37C. The levels of bioluminescence were determined in continuous imaging mode 
at high resolution with 5 min exposure times.  
   
Growth and fluorescence assays in gfp+ strains 
Broth-based assays were performed by inoculating fully grown L. salivarius strains 
containing the promoter.gfp+ gene fusions at 2% w/v in a volume of 0.2 mL of media (MRS) 
and grown statically at 37C. The optical density at 600nm was monitored to determine 
bacterial growth or to detect GFP fluorescence (excitation 485nm, emission 520nm) in a 
Synergy 2 spectrophotometer (Bio-tek, Winooski, VT, USA) over a 20 h period. Data was 
recorded and plotted in relative fluorescence units (RFU).  
 
Challenge assays to environmental stimuli and stresses 
Stationary phase cells of L. salivarius gfp+ strains were harvested by centrifugation and cell 
pellets were washed with PBS and resuspended in MRS broth. Cells were then inoculated at 
2% w/v into 1mL MRS broth at pH6.5, pH6 and pH5.5 (adjusted with 1M HCL), into MRS 
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broth containing 0.25, 0.5% and 1% w/v NaCl concentrations or in to MRS broth containing 
0.1, 0.2% and 0.3% porcine bile (Sigma-Aldrich, St. Louis, MO, USA). 0.2 mL aliquots were 
dispensed in to 96-well plates and monitored as described above.  
 To assess GFP expression from cells in response to the presence of target microbes, 
gfp+ strains were inoculated at 1 x 10
9
 CFU/mL in to MRS broth with a bacteriocin sensitive 
strain (Lactobacillus delbrueckii subsp. bulgaricus LMG 6901) at 1 x 10
7
 CFU/mL. GFP 
expression was monitored in 96-well plates as described above. To assess promoter activity 
in the presence of bacteriocin inducing peptides (IP), the recognised IP for salivaricin P 
(MKFEVLTEKKLQVIVGGKQEGGTKTYDKVCRFKFLGICK) and the IP that is specific to 
both salivaricin T and ABP-118 (MKFEVLTEKKLQKIAGGATKKGGFKRWQCIFTFFGVCK) 
were synthesised using Microwave-assisted Solid Phase Peptide Synthesis (MW-SPPS) 
performed on a LibertyBlue
TM
 CEM microwave peptide synthesiser. Both peptides were 
synthesised on an Fmoc-L-Lys(BOC) HMBP-Chemmatrix resin (PCAS BioMatrixInc, 
Quebec, Canada) and purified using RP-HPLC on a Vydac C8 (10 u, 300A) column (Vydac, 
California, USA) and eluted using a 20-40% acetonitrile 0.1% TFA gradient over 40 minutes. 
The flow rate was 2.5 ml/min and eluent monitored at 214 nm. Fractions containing the 
desired molecular mass were identified using MALDI TOF Mass Spectrometry (Shimadzu 
Biotech, Manchester UK) and were pooled and lyophilised on a Genevac HT 4X (Genevac 
Ltd. Ipswich, UK) lyophiliser. Peptides were added to harvested cells in MRS broth at 10
-4
-
10
-6
M and fluorescence was monitored over 20 h as described above.  
 
Challenge assays to simulated gastric fluid 
To assess GFP expression from cells exposed to simulated gastric fluid overnight cells were 
washed in PBS and subsequently resuspended in gastric fluid for 30 secs, 1 min and 5 min. 
Cells were then harvested and inoculated into MRS broth and fluorescence was detected as 
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described above. Simulated gastric fluid was made as previously described (32) consisting of 
NaCl (2.05 g/L), KH2PO4 (0.60 g/L), CaCl2 (0.11 g/L) and KCl (0.37 g/L), adjusted to pH 2.0 
using 1M HCl and autoclaved at 121C for 15 min. Porcine bile (0.05 g/L), lysozyme (0.1 
g/L) and pepsin (0.0133 g/L) were added as stock solutions prior to use. Components were 
obtained from Sigma-Aldrich (St. Louis, MO, USA). 
 
RESULTS  
Selection of a reporter system for L. salivarius 
The GFP, RFP and Lux reporter systems were investigated to test their suitability as tools to 
study promoter activity in L. salivarius. Due to the potential usefulness of the Lux system 
with respect to facilitating in vivo detection (33), the creation of a luciferase reporter system 
in L. salivarius strains was targeted. The synthetic Lux operon, containing luxABCDE, 
encoding luciferase (LuxAB) and a fatty acid reductase complex (LuxCDE) was amplified 
from the pP2lux plasmid (34) and cloned after the constitutively expressed p44 promoter in 
the pNZ44 plasmid. Although notable bioluminescence was obtained in the E. coli host (Fig. 
1), L. salivarius cells containing this vector did not generate bioluminescence of sufficient 
strength to merit its continued use.  
DsRed is a popular reporter protein of RFP and often used as an alternative to GFP 
due to the generation of a more optimal emission spectrum for fluorescence within complex 
and live tissues (for review see (35)). The DsRed reporter protein is available commercially 
as part of a transcriptional fusion with lacZ (Clontech). However, when the dsred ORF is 
moved to another vector it is often not efficiently expressed and can develop more slowly 
than GFP (29, 36). To optimise the production of RFP, steps were taken in the 
oligonucleotide design to reduce the GC content at the start at the 5` end of the gene and a 
typical RBS ACGAGG was inserted 8 bp before the translational start site, as previously 
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suggested (29) (Table S1). Despite noticeable fluorescence in E. coli, upon transferring the 
pNZ44.rfp vector into L. salivarius, we were again unable to detect sufficient fluorescence 
from fully grown cultures to justify its continued use (Fig. 1).    
GFP is a highly useful stable and species-independent fluorescent reporter and, unlike 
bioluminescent reporters, does not require the addition of specific substrates (other than 
molecular oxygen) for reaction efficiency. Following synthesis, GFP requires an autocatalytic 
reaction creating a fluorophore by oxidation (37). Previous work has established that GFP can 
be used as a reporter in L. salivarius cells (38). In this study the gfp gene with a 
corresponding RBS site (AGGAGG) was cloned downstream of the constitutive Lactococcus 
lactis p44 promoter and fluorescence was observed. The p44 promoter was replaced with a 
constitutive Lactobacillus promoter pcysk (from L. salivarius NCIMB 40829 
(LSUCC118
TM
)), and although the level of fluorescence observed was indeed higher, it was 
reasonably comparable with that detected with the p44 promoter and therefore continued use 
of the lactococcal promoter fusions as a  positive control for GFP expression was sufficient 
(Table 2; Fig. 1). 
Notably, although a very useful reporter in vitro, in vivo analysis using gfp+ L. 
salivarius cells were previously not successful due to background tissue, and indeed food, 
autofluorescence (unpublished data) and therefore in vitro tests were relied upon to 
investigate the impact of environmental stresses on promoter activity.   
 
In silico analysis of bacteriocin promoter regions 
The bacteriocin clusters associated with bactofencin A, salivaricin P, T and ABP-118 were 
examined to identify promoter sequences preceding the genes encoding the bacteriocin 
structural peptides (Fig. 2). Specifically, regions were examined for typical sigma 70 motifs 
(-10 (TATAAT) and -35 sequences (TTGACA)) and direct repeats using manual annotation 
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and promoter mining software. Directly upstream of the bactofencin A start codon was a 
predicted sigma 70 promoter with -10 and -35 motifs located 16 bp apart and 23 bp upstream 
from the likely RBS site (Fig. 2a). A fragment of 110 bp incorporating this intergenic region 
was amplified and fused directly to the gfp gene in the pNZ44 plasmid to make bfnAprom.gfp 
(Table 2).  
Analysis of the regions upstream of the prepeptide and structural genes in the class IIb 
bacteriocins did not reveal correspondingly obvious promoter regions. Alignment of the 
intergenic regions from the gene clusters highlight a very high sequence similarity (Fig. 2 b-
d), with 98-99% nucleotide identity across the putative promoter regions for these 
bacteriocins and therefore, in certain cases, the same constructs were used to represent one 
putative promoter region (Table 2). In all, 4 regions, including (i) an ABP118-specific region 
of 345bp upstream of the ABP-118 prepeptide and (ii-iv) 3 promoter regions (salprom1-3) 
ranging from 151bp-847bp representing 3 upstream regions of the structural genes of 
salivaricin P and salivaricin T, were amplified (Fig. 2b-d). salprom1 represents a small 
putative promoter region (Fig S1) upstream of the bacteriocin prepeptide, whereas the larger 
regions (salprom2 and salprom3) were included to ensure cloning of promoter regions that 
may be located further upstream (Table 2). 
Care was taken in the cloning of the larger regions to reduce the amount of translated 
nucleotides included in the final constructs. To create a bank of gfp+ strains, the promoter.gfp 
fusions were transformed (in most cases; Table S2) into each of the 4 bacteriocin-producing 
strains; L. salivarius DPC6502 (bactofencin A producer), L. salivarius DPC6488 (salivaricin 
TL producer), L. salivarius DPC6189 (salivaricin P and bactofencin A producer) and L. 
salivarius NCIMB 40829 (LSUCC118
TM
) (ABP-118 producer). In addition, a promoter-less 
construct containing the gfp gene was also made in each background to serve as a negative 
control (Table 2 and Table S2).  
14 
 
 
In vitro analysis the promoter region of the class IId bacteriocin bactofencin A 
The strength of the putative promoter regions from the bacteriocin clusters were assessed 
using GFP as a reporter. Initially each bacteriocin promoter was analysed in the natural 
background where the corresponding bacteriocin is produced. A comparison of fluorescence 
was performed by visualising stationary phase cells under a fluorescence microscope and 
followed by a comparison of expression monitored over 20 h of growth (Fig. S2). Cloning of 
the promoter region bfnAprom highlighted strong promoter activity initially in the L. 
salivarius DPC6502 (bactofencin A-producing) background, which increased further during 
the logarithmic growth phase (Fig. 3a). It should be noted here that T0 RFU readings are 
higher than expected; this is possibly due to an initial adjustment of the instrument. 
Analysis revealed also that although the bactofencin A promoter is switched on in all 
4 backgrounds tested, GFP expression was at a lower level in the backgrounds where 
bactofencin A is naturally produced, i.e. L. salivarius DPC6502 and L. salivarius DPC6189, 
than in the backgrounds where the bacteriocin is not encoded, i.e. L. salivarius NCIMB 
40829 (LSUCC118
TM
) and L. salivarius DPC6488. This was evident during growth analysis 
in log phase (Fig. 3b) and also when washed cells were viewed under a fluorescence 
microscope (Fig.  3c).  
  
In vitro analysis of the promoter regions of the structural genes of class IIb bacteriocins  
The predicted promoter regions (salprom1-3 and abp-118prom) representing salivaricin P, 
salivaricin T and ABP-118 respectively were expressed as GFP fusions in each of salivaricin-
producing backgrounds to analyse promoter activity (Table S2). In all instances, these 
promoters exhibited weak expression during growth analysis in MRS broth (represented by 
salprom2 in Fig. 4). Indeed, relative fluorescence units (RFU) values resembled those of the 
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negative (promoter-less GFP) control (Fig. 4). An increase in promoter activity was not 
observed with either salprom1 or salprom3 in the L. salivarius DPC6189 background (not 
shown). It was thought that this may be due to an insufficient level of IP production and so 
the predicted inducing peptide for salivaricin P and for the salivaricin T/ABP-118 (genes 
corresponding to the IPs for salivaricin T and ABP-118 show 100 % nucleotide identity) were 
synthesised and added at varying concentrations and fluorescence was monitored over 20h. 
The addition of 10
-5 
M of the salivaricinT/ABP-118 IP to cells expressing the promoter 
region salprom2 and abp-118prom resulted in an increase in fluorescence over time 
(represented by salprom2 in Fig. 4). The use of the ABP-118 IP to induce bacteriocin activity 
in L. salivarius NCIMB 40829 (LSUCC118
TM
) has been previously reported (11).   
 
Bacteriocin promoter activity under simulated environmental conditions 
A number of challenge assays were undertaken to establish if environmental signals, and in 
particular those associated with the GIT, could induce bacteriocin promoter activity with a 
view to determining if the bacteriocins might still be produced under the stressful conditions 
present in the gut or if information could be gained that would facilitate enhanced bacteriocin 
production in a processing environment. Cells containing the promoter.gfp fusions were 
challenged and analysed for promoter activity at sub-inhibitory growth levels of low pH, salt, 
bile, in the presence of target microbes and at low levels of simulated gastric juice. For each 
challenge assay, specific promoter fusions were analysed in their own bacteriocin-producing 
backgrounds. The bactofencin A promoter was functional under all conditions tested 
including at examples of low pH [5.5], in the presence of bile [0.2% (w/v)] or in the presence 
of target microbes, with GFP expression comparable to that detected in the L. salivarius 
DPC6502 strain in lab media (data not shown). In the presence of low levels of added salt 
[0.25-0.5% (w/v)], promoter activity actually increased and had higher GFP levels than 
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controls (Fig 5a). Cells were also exposed for short times (30 secs, 1 min and 5 mins) to 
gastric fluid [pH2], mimicking the conditions of the upper intestinal tract.  Under these 
stressful conditions, GFP expression increased, indicating induction of bfnAprom when 
exposed to the harsh conditions such as those encountered in the gut (Fig 5b). 
 The class IIb bacteriocin promoter regions were also tested in response to 
environmental stresses described above, however no significant increase in promoter activity 
was observed (data not shown).  
 
DISCUSSION 
Bacteriocins have great potential as therapeutic agents that can be used to inhibit important 
pathogens in food and/or clinical settings. The level at which bacteriocins are produced under 
stressful environmental conditions is not an area that has been extensively explored. In this 
study, we used a stable expression system for monitoring the activity of L. salivarius-
associated bacteriocin promoters under various environmental conditions.  
 This study initially analysed 3 different potential reporter systems to study promoter 
activity in L. salivarius cells. The GFP reporter was found to be more optimal in the 
bacteriocin-producing backgrounds than either the RFP or Lux representatives. Interestingly, 
a very recent study has reported the development of an optimised GFP variant suitable for 
anaerobic environments (39) as the strains expressing GFP in this study were analysed under 
microaerobic conditions to facilitate fluorescence detection. Both the RFP and Lux systems 
were also investigated due to their usefulness in live tissues. However, neither system 
facilitated efficient reporter expression in L. salivarius. This is in accordance with previous 
work on the Lux system whereby it was suggested that the L. salivarius genome does not 
contain the genetic machinery to support the light emitting reaction. The authors suggested 
that L. salivarius lacks a NAD(P)H:FMN oxidoreductase, which functions to synthesise 
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reduced flavin mononucleotide (FMNH2) required to emit bioluminescence in the presence 
of oxygen (38). There are limited studies on the use of the DsRed (RFP) protein in 
Lactobacillus spp. but there have been some reports of RFP expression in Lactobacillus cells 
(40). In this work the expression of the DsRed (RFP) protein was initially optimised for 
expression in E. coli but was not efficiently expressed in L. salivarius. This may be due to 
weak RBS initiation in the Lactobacillus background but further analysis would be required 
to determine this.  
Assessment of the class IId bacteriocin bactofencin A promoter.gfp fusions revealed a 
strong promoter active under all environmental stresses, the activity of which could be 
increased under specific conditions and when introduced into non-bactofencin A producing 
strains (Fig. 3). It may be that, as for some other bacteriocin clusters, the associated promoter 
is switched on at a basal level in all conditions but once the bacteriocin peptide reaches a 
certain threshold, promoter activity is switched off or repressed (Fig. S3). The genetic 
determinants for such a bactofencin A-associated regulatory pathway have yet to be identified 
but, now that the existence of such a mechanism has been indicated, it will be the focus of 
further studies. In addition, the increased promoter activity upon exposure to mild stresses 
such as low levels of salt and simulated gastric fluid (Fig. 5) that may mimic the conditions of 
the GIT suggest the potential to use this bacteriocin to inhibit gut pathogens in vivo. Given 
that gastric fluid contains salt, we cannot preclude the possibility that salt also plays a key 
role in promoter induction in this environment.     
 Analysis of the genomic regions upstream of the structural genes of the 3 class IIb 
bacteriocins, salivaricin P, salivaricin T and ABP-118, did not reveal obvious promoter 
regions. However, these promoter regions are likely to be bound by a response regulator from 
a two-component system and therefore may not contain typical sigma 70 promoter motifs. In 
addition, it should be noted that in low GC organisms, stretches resembling – 10 elements can 
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be frequent and therefore definitive identification of promoter elements can be challenging. 
The in vitro assays investigating the promoters from the class IIb bacteriocins revealed 
apparent weak expression. Given that the addition of the IP stimulated promoter activity (Fig. 
4), it is likely that the full promoter region is indeed cloned and active but sensitive to the 
levels of IP available.  
 In conclusion, this study investigated the activity of the promoters of bacteriocin 
production in L. salivarius. The results highlight the capacity for salt (bactofencin A) or an 
induction peptide (class IIb salivaricins) to induce promoter activity, information that can be 
taken advantage of to increase bacteriocin production in the GIT or in the processing 
environment.    
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Figure Legends 
Fig. 1  Schematic representation of the pNZ-based fluorescent plasmids constructed for the 
expression of gfp, rfp and lux genes in E. coli and L. salivarius cells.   
 
Fig. 2 In silico analysis of the bactofencin A putative promoter region upstream of the 
bactofencin structural gene (a). Alignment of the structural genes, immunity genes and the 
intergenic regions of the class IIb bacteriocins salivaricin P (b), ABP-118 (c) and salivaricin 
TL (d).  
Red arrows; bacteriocin structural genes, orange arrows; genes encoding bacteriocin 
prepeptide, green arrows; regulatory genes/transport genes, white arrow; genes encoding 
bacteriocin inducing peptides, purple arrow; bacteriocin immunity genes. The green blocks 
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between clusters represent regions of high % nucleotide identity from within the promoter 
regions were amplified. The grey blocks represent regions of high % nucleotide identity in 
the surrounding genes. The values of % nucleotide identity are included within the panels.   
 
Fig. 3 Production of total fluorescence (as measured by RFU) produced by the bfnAprom.gfp 
plasmid in the bactofencin A producer L. salivarius DPC6502 (green bar chart) and growth 
analysis of the L. salivarius DPC6502 strain over time as measured by OD 600nm (a).  
Production of total fluorescence produced by the bfnAprom.gfp plasmid in bacteriocin 
producers L. salivarius UCC118;     , DPC6502;     , DPC6189;    , DPC6488; .  
The underneath panel shows L. salivarius DPC6189 (BfnA +ve) and L. salivarius DPC6488 
(BfnA –ve) expressing bfnAprom.GFP cultures under a fluorescence microscope (c). 
 
Fig. 4 Production of total fluorescence (as measured by RFU) produced by the salprom2.gfp 
in L. salivarius UCC118 in MRS broth and in response to 10
-5
 M ABP-118/salT IP.        
 gfp negative control;      , salprom2 in MRS broth;     , salprom2 in MRS broth with IP    .  
 
Fig. 5 Production of total fluorescence (as measured by RFU) produced by bfnAprom.gfp in 
L. salivarius DPC6502 in response to salt (a) and to simulated GI fluid (b).    bfnAprom.gfp in 
MRS broth;   ,   bfnAprom.gfp in MRS broth with 0.5% w/v NaCl;    , bfnAprom.gfp in MRS 
broth following 5 min exposure to simulated GI fluid;   .  
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Table 1. Strains and plasmids used in this study 
Strain or Plasmid Relevant Properties Source or Reference 
Strains 
E. coli 
   DH10B 
 
 
 
L. salivarius  
   UCC118
 
    
   DPC 6488 
 
   DPC 6502 
 
   DPC 6189 
 
L. delbrueckii subsp. 
bulgaricus  
   LMG 6901 
 
Plasmids 
   pNZ44 
 
   pEVSgfp+ 
 
   pDsRed express     
   vector 
 
   pPl2Lux 
   
 
 
F- mcrA Δ( mrr-hsdRMS-mcrBC) Φ80lacZΔM15 
Δ lacX74 recA1 araD139 Δ(araleu)7697 galU galK rpsL 
(StrR) endA1 nupG. Host for pNZ44 fluorescent 
derivatives. 
 
Human ileocecal isolate, ABP-118 bacteriocin producer 
 
Human isolate, Salivaricin TL producer 
 
Porcine isolate, Bactofencin A producer 
 
Porcine isolate, Salivaricin P and Bactofencin A producer 
 
 
Bacteriocin sensitive indicator 
 
 
 
Cm
 r
,
 
Lactococcal expression vector
 
 
source of gfp gene 
 
Amp
r
, lacZ-DsRed-Express fusion protein 
 
 
Derivative of the listerial integration vector pPL2 and 
harbors the synthetic luxABCDE 
 
 
Life Technologies  
 
 
 
 
(11) 
 
(8) 
 
(9) 
 
(8, 13) 
 
 
(13) 
 
 
 
(41) 
 
(28) 
 
Clontech 
 
(30) 
 
Cm
r
: chloramphenicol resistance; Amp
r
: Ampicillin resistance  
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Table 2: Fluorescence plasmids constructed in this study 
 
  
Plasmid Relevant Properties 
 
pNZ44.gfp 
 
pNZ.gfp-   
pNZ44.rfp 
pNZ44.lux 
cyskprom.gfp 
bfnAprom.gfp 
   
 abp-118prom.gfp 
 
 salprom1.gfp 
    
  
 
salprom2.gfp 
    
 
  
salprom3.gfp 
  
 
 
pNZ44 plasmid with the gfp gene fused to the p44 promoter. 
promoter less pNZ44 derived plasmid containing the intact gfp gene. 
pNZ44 plasmid with the rfp gene fused to the p44 promoter. 
pNZ44 plasmid containing the  luxABCDE genes fused to the p44 promoter. 
pNZ44 plasmid containing the  gfp gene, the p44 promoter is replaced with the promoter of 
the cysK gene of L. salivarius UCC118 
pNZ44 plasmid containing the  gfp gene, the p44 promoter is replaced with the putative 
promoter of the bactofencin A structural gene of L. salivarius DPC6502 
pNZ44 plasmid containing the  gfp gene, the p44 promoter replaced with the putative 
promoter region upstream of the ABP-118 prepeptide of  L. salivarius  UCC118 
pNZ44 plasmid containing the gfp gene, the p44 promoter is replaced with an 847bp region 
upstream of the salivaricin P and T structural genes of L. salivarius DPC6189 and 
DPC6488 respectively. (Oligonucleotides used include salprom1For and  salprom2Rev in 
which cloned insert begins 847 bp upstream of the start codon of the structural gene (salT  
of DPC6488 and sln1 of DPC6005).  
pNZ44 plasmid containing the  gfp gene, the p44 promoter is replaced with a 391bp region 
upstream of the salivaricin P and T structural genes  of L. salivarius DPC6189 and 
DPC6488 respectively. (Oligonucleotides used include salprom2For and  salprom2Rev in 
which cloned insert begins 391 bp upstream of the start codon of the strucutural gene salT 
 of DPC6488 and sln1 of DPC6005). 
pNZ44 plasmid containing the gfp gene, the p44 promoter is replaced with the synthesised 
151bp region (sequence in Fig S1) upstream of the salivaricin P and T prepeptide of L. 
salivarius DPC6189 and DPC6488  respectively. 
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Fig. 5  
